AWS-JHU Antibody Developability Benchmark

First large-scale heterogeneous antibody developability dataset with 50 seed antibodies across 4 structural formats, 42 antigens, 6 developability traits, all wet-lab validated. Supports zero-shot evaluation.

Composite
72.3
Experimental validation
Wet-lab confirmed
Stages
Developmental CandidateLead ID / ADMET
Modalities
biologic
Task types
classificationregression
Size
seed_antibodies: 50
structural_formats: 4
antigens: 42
developability_traits: 6
License
Other
First release
2026-04-14
Last updated
2026-04-14
Official site
→ project page
Leaderboard
→ leaderboard
Dataset
→ dataset
Code / GitHub
→ repository
HuggingFace
→ HF
Paper
AWS-JHU Antibody Developability Benchmark · Jeffrey Gray, AWS AI Labs · 2026 · paper · doi:N/A — paper pending · 0 citations
Flags
none
Experts
Groups
Hosted by
Related benchmarks
FLAb2 (Fitness Landscape for Antibodies 2), BenchBB (Bench-tested Binder Benchmark), AbBiBench (Antibody Binding Benchmark)

Rubric (7-criterion)

rigor
4
coverage
3
maintenance
4
adoption
2
quality
5
accessibility
3
industry_relevance
5

Notes

Groundbreaking for antibody developability — fills gap where most benchmarks focus on binding only. Wet-lab validated ground truth across diverse formats. Zero-shot evaluation support is novel. AWS backing suggests long maintenance.

← Back to all benchmarks

Compare:
Open comparison →